Iron acquisition strategies in pathogenic fungi
mBio · 11.06.2025 · 16 (6)
DOI: 10.1128/mbio.01211-25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift mBio, erschienen am 11.06.2025. Verfasst von Kathryn Takemura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Drug Discovery, Stony Brook, New York, USA. Hauptthemen laut MEDLINE: Iron, Fungi. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, BLRD VA, U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
Iron plays a crucial role in various biological processes, including enzyme function, DNA replication, energy production, oxygen transport, lipid, and carbon metabolism. Although it is abundant in the Earth’s crust, its bioavailability is restricted by the insolubility of ferric iron (Fe³ + ) and the auto-oxidation of ferrous iron (Fe² + ) in oxygen-rich environments. This limitation poses significant challenges for all organisms, including fungi, which have developed intricate mechanisms for iron acquisition and utilization. These mechanisms include reductive iron uptake, siderophore production/transport, and heme utilization. Fungi employ a variety of enzymes—such as ferric reductases, ferroxidases, permeases, and transporters—to regulate intracellular iron levels effectively. The challenge is heightened for pathogenic fungi during infection, as they must compete with the host’s iron-binding proteins like transferrin and lactoferrin, which sequester iron to restrict pathogen growth. This review delves into the iron acquisition strategies of medically important fungi, emphasizing the roles of reductive iron uptake and siderophore pathways. Understanding these mechanisms is vital for enhancing our knowledge of fungal pathogenesis and developing effective treatments. By targeting these iron acquisition processes, new antifungal therapies can be formulated more effectively to combat fungal infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology and Drug Discovery, Stony Brook, New York, USA.
- Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.
- Division of Infectious Diseases, School of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Veterans Affairs Medical Center, Northport, New York, USA.
ORCID-Profile: Maurizio Del Poeta, Nivea Pereira de Sa
Förderung
- National Institute of Allergy and Infectious Diseases
- BLRD VA
- U.S. Department of Veterans Affairs
- U.S. Department of Defense
- NIAID NIH HHS
Zitieren
APA
Takemura, K., Kolasinski, V., Del Poeta, M., Vieira de Sa, N. F., Garg, A., Ojima, I., Del Poeta, M., & Pereira de Sa, N. (2025). Iron acquisition strategies in pathogenic fungi. mBio, 16(6). https://doi.org/10.1128/mbio.01211-25
Vancouver
Takemura K, Kolasinski V, Del Poeta M, Vieira de Sa NF, Garg A, Ojima I, et al. Iron acquisition strategies in pathogenic fungi. mBio. 2025;16(6). doi:10.1128/mbio.01211-25
BibTeX
@article{Takemura2025,
author = {Takemura, Kathryn and Kolasinski, Vanessa and Del Poeta, Matteo and Vieira de Sa, Nathalia Fidelis and Garg, Ashna and Ojima, Iwao and Del Poeta, Maurizio and Pereira de Sa, Nivea},
title = {Iron acquisition strategies in pathogenic fungi},
journal = {mBio},
year = {2025},
volume = {16},
number = {6},
doi = {10.1128/mbio.01211-25}
}
EUVIMED